Lead researcher, Dr. David Vossler, MD, FAAN FACNS FAES, Department of Neurology, University of Washington, discusses the recent U.S. FDA approval of UCB’s VIMPAT® (lacosamide) CV as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older and VIMPAT injection for intravenous use in children four years of age and older.
Author: healthprofessionalradio
Immunotherapy for Children At Risk – Type 1 Diabetes
Returning guest, Dr. Adriana Carrillo-Iregui, pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital discusses immunotherapy for at risk children that is an emerging treatment for Type 1 diabetes. She explains how it works and which pediatric patients are candidates for this drug.
New Approach for Managing Hemophilia A
Dr. Amy Shapiro, hematologist-oncologist and CEO and co-medical director at the Indiana Hemophilia & Thrombosis Center, Inc., discusses important treatment developments that have brought hope to people living with hemophilia A. She is joined by Guy who is living with hemophilia A.
The Holiday Season and Mental Health
Dr. Jessica Whelan, family psychiatric nurse practitioner discusses why the holiday season can be particularly challenging for people living with mental health conditions like bipolar I disorder, the difference between holiday blues and bipolar I disorder, and a treatment option people living with bipolar I disorder can discuss with their doctors. Visit www.vraylar.com to learn more including additional safety information.
COVID-19, Vitamin D deficiency , and Post-Viral Energy Depletion
Returning guest, board-certified internist, Dr. Jacob Teitelbaum discusses a recent study published in the “American Journal of Clinical Pathology” (Nov 2020) that showed that 59 percent of patients with COVID-19 are vitamin D-deficient when they’re admitted; and the deficiency was most pronounced in men with advanced stages of COVID-related pneumonia. He also talks about the long term effects of COVID-19, known as “long-hauler syndrome” and his clinical work and research on post-viral energy depletion.
Nkarta – Allogeneic CAR Natural Killer (NK) Cell Therapy
Paul Hastings, CEO of Nkarta Therapeutics discusses results from their NKX101 study, an allogeneic CAR Natural Killer (NK) cell therapy, in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (MDS).
Underdiagnosed COPD
Dr. Riju Ray, MD, PhD, Senior Medical Lead at GSK, leading U.S. medical affairs across asthma and COPD, discusses a recent (Dec 2020) study funded by GSK and co-developed by GSK and CHEST as part of the CHEST “Clinical Perspectives” series evaluating the role of pulmonologists, COPD exacerbations, and the need to improve COPD management and education.
Type 1 Diabetes Mellitus – Genetics and Environmental Factors Study
Dr. Adriana Carrillo-Iregui, pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital discusses the TEDDY study (The Environmental Determinants of Diabetes in the Young), a national study to find out why type 1 diabetes mellitus (T1DM) is on the rise in children. Early data shows that genetic predisposition and environmental factors play a role in the cause of T1 diabetes.
Coronary Microvascular Dysfunction (CMD)
Dr. C. Noel Bairey Merz, MD, Director of the Barbra Streisand Women’s Heart Center, the Linda Joy Pollin Women’s Heart Health Program, the Erika J. Glazer Women’s Heart Research Initiative, and the Preventive Cardiac Center at the Smidt Cedars-Sinai Heart Institute discusses coronary microvascular dysfunction (CMD), and how to identify and assist patients living with CMD against the backdrop of a pandemic. She talks about what cardiologists and general practitioners should know about CMD and its warning signs, and the developing treatment options in the space.
Protective Masks and Related Skin Issues
Returning guest, Dr. Julie Harper, board-certified dermatologist and Galderma consultant, discusses maskne, seasonal acne and related treatment options. She also discusses the burden and stigma around acne and her experience treating acne via telehealth.